| Product Code: ETC6011284 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Lung Cancer Therapeutics Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 Afghanistan Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.7 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
4 Afghanistan Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Afghanistan |
4.2.2 Growing awareness about lung cancer screening and treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and access to cancer care services |
4.3 Market Restraints |
4.3.1 Limited access to advanced lung cancer therapies in remote areas of Afghanistan |
4.3.2 High cost of lung cancer treatments and limited insurance coverage |
4.3.3 Lack of skilled healthcare professionals specialized in lung cancer care |
5 Afghanistan Lung Cancer Therapeutics Market Trends |
6 Afghanistan Lung Cancer Therapeutics Market, By Types |
6.1 Afghanistan Lung Cancer Therapeutics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021- 2031F |
6.1.4 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Metastatic Lung Cancer, 2021- 2031F |
6.1.5 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Pulmonary Neuroendocrine Tumors, 2021- 2031F |
6.1.6 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Mediastinal Tumors, 2021- 2031F |
6.1.7 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.8 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Chest Wall Tumors, 2021- 2031F |
6.2 Afghanistan Lung Cancer Therapeutics Market, By Molecule Type |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3 Afghanistan Lung Cancer Therapeutics Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Alkylating Agents, 2021- 2031F |
6.3.3 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.3.4 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By EGFR Inhibitors, 2021- 2031F |
6.3.5 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Mitotic Inhibitors, 2021- 2031F |
6.3.6 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Multikinase Inhibitors, 2021- 2031F |
6.4 Afghanistan Lung Cancer Therapeutics Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.3 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.5 Afghanistan Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
7 Afghanistan Lung Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 Afghanistan Lung Cancer Therapeutics Market Export to Major Countries |
7.2 Afghanistan Lung Cancer Therapeutics Market Imports from Major Countries |
8 Afghanistan Lung Cancer Therapeutics Market Key Performance Indicators |
8.1 Percentage increase in early-stage lung cancer diagnosis rates |
8.2 Number of new lung cancer treatment facilities established |
8.3 Patient survival rates at 1-year post-treatment |
9 Afghanistan Lung Cancer Therapeutics Market - Opportunity Assessment |
9.1 Afghanistan Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Afghanistan Lung Cancer Therapeutics Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.3 Afghanistan Lung Cancer Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 Afghanistan Lung Cancer Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10 Afghanistan Lung Cancer Therapeutics Market - Competitive Landscape |
10.1 Afghanistan Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here